In April, we covered NAD’s decision involving Tru Niagen, a nicotinamide riboside dietary supplement marketed to support NAD+ levels. NARB has now aff
| less than a minute read
Stay ADvised: Net Impression Matters—NAD, FTC, AGs, and NARB Turn Up the Heat

/Passle/68de3c97bf7349bdd953bb7f/SearchServiceImages/2026-06-01-18-41-03-987-6a1dd23f8a10fa74d36f6389.jpg)
/Passle/68de3c97bf7349bdd953bb7f/SearchServiceImages/2026-05-29-18-34-32-553-6a19dc38d80437c18c40cc12.jpg)
/Passle/68de3c97bf7349bdd953bb7f/SearchServiceImages/2026-05-29-18-32-10-391-6a19dbaa6f657df32a4e8876.jpg)
/Passle/68de3c97bf7349bdd953bb7f/SearchServiceImages/2026-05-29-18-30-20-888-6a19db3c6f657df32a4e85fb.jpg)